Flushing the Myths: Revisiting Vancomycin Allergy Labeling through a Clinical Audit

World Allergy Organization Journal 2026 Open access

Read full text
Authors: Reem Elajez, Dana Bakdach, Hend Abdulla AlNaimi, Mohamed Badran, Rana Al-Adawi, Asmaa Mohamed
DOI: 10.1016/j.waojou.2026.101328
Cited by: 0
References: 1

Abstract

Vancomycin is a first-line treatment for many gram-positive infections. Vancomycin infusion reactions (VIR), previously termed “Red Man Syndrome” may mimic true allergy responses, leading to mislabeling, unnecessary avoidance, and limited therapeutic options.

Fields of Study & Subjects

Drug-Induced Adverse Reactions Pharmacovigilance and Adverse Drug Reactions Food Allergy and Anaphylaxis Research

Publication details

Journal / source
World Allergy Organization Journal
Volume
19
Issue
2
Pages
101328–101328
Publication date
1 February 2026
Language
EN